Kratom

The FDA’s Proposed Kratom Ban is a Mistake

[ad_1] Trust in the U.S. Food and Drug Administration (FDA) declined after its approval of the controversial Alzheimer’s drug aducanumab. Three experts resigned amid allegations that the FDA had caved to industry pressure. Some argue that its credibility has reached a new low. These events should have prompted the FDA to pause, reflect, and work to repair its reputation. Instead, …

The FDA’s Proposed Kratom Ban is a Mistake Read More »

Shopping Cart